ArticleLife metabolism2023

Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial.

Yuzhou Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.